{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T06:54:09Z","timestamp":1760079249121},"reference-count":13,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2005,12,9]],"date-time":"2005-12-09T00:00:00Z","timestamp":1134086400000},"content-version":"vor","delay-in-days":6066,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arthritis &amp; Rheumatism"],"published-print":{"date-parts":[[1989,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Nine severely ill patients with a confirmed diagnosis of systemic juvenile rheumatoid arthritis were treated with recombinant \u03b3\u2010interferon (\u03b3\u2010IFN) in addition to the therapy they were previously receiving for their disease. Improvements in clinical symptoms were noted in 7 of the patients, and median laboratory values also showed a marked improvement after \u03b3\u2010IFN treatment. A relapse occurred in 1 patient. The results of this study should stimulate further research on the use of \u03b3\u2010IFN in systemic juvenile rheumatoid arthritis, particularly in determining the appropriate effective dosage.<\/jats:p>","DOI":"10.1002\/anr.1780320520","type":"journal-article","created":{"date-parts":[[2007,2,14]],"date-time":"2007-02-14T23:14:03Z","timestamp":1171494843000},"page":"643-646","source":"Crossref","is-referenced-by-count":22,"title":["Therapy for systemic juvenile rheumatoid arthritis with \u03b3\u2010interferon: A pilot study of nine patients"],"prefix":"10.1002","volume":"32","author":[{"given":"W.","family":"Pernice","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Schuchmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Dippell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Suschke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Truckenbrodt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Schindera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ch.","family":"Humburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Brzoska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,12,14]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00271840"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5699(87)90212-X"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1047993"},{"key":"e_1_2_1_5_2","first-page":"712","article-title":"Criteria for the classification of juvenile rheumatoid arthritis","volume":"23","author":"Brewer EJ","year":"1972","journal-title":"Bull Rheum Dis"},{"key":"e_1_2_1_6_2","doi-asserted-by":"crossref","first-page":"4238","DOI":"10.4049\/jimmunol.140.12.4238","article-title":"IL\u20101 induces IL\u20101. III. Specific inhibition of IL\u20101 production by IFN\u2010\u03b3","volume":"140","author":"Ghezzi P","year":"1988","journal-title":"J Immunol"},{"key":"e_1_2_1_7_2","first-page":"1410","article-title":"Interferon gamma: Ein janus\u2010k\u00f6pfiger Mediator bei Entz\u00fcndungen","volume":"37","author":"Brzoska J","year":"1987","journal-title":"Arzneimittelforschung"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1089\/jir.1987.7.559"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3083.1988.tb02324.x"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.3109\/03009748709102926"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1159\/000233615"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0090-1229(87)90175-9"},{"key":"e_1_2_1_13_2","first-page":"88","article-title":"Cytokines in synovial fluid. II. The presence of tumor necrosis factor and interferon","volume":"73","author":"Hopkins SJ","year":"1988","journal-title":"Clin Exp Immunol"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1949.02900430001001"}],"container-title":["Arthritis &amp; Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fanr.1780320520","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/anr.1780320520","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T21:45:18Z","timestamp":1700689518000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/anr.1780320520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1989,5]]},"references-count":13,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1989,5]]}},"alternative-id":["10.1002\/anr.1780320520"],"URL":"https:\/\/doi.org\/10.1002\/anr.1780320520","archive":["Portico"],"relation":{},"ISSN":["0004-3591","1529-0131"],"issn-type":[{"value":"0004-3591","type":"print"},{"value":"1529-0131","type":"electronic"}],"subject":[],"published":{"date-parts":[[1989,5]]}}}